in the first rotavirus season. Vaccine efficacy in the second season was 62.6% against any RV gastroenteritis and 88% against severe disease. Vaccine efficacy in reducing hospitalizations and ...

the study was conducted during the peak rotavirus season. In conclusion, the findings of our survey indicate that US providers are aware of the health burden of rotavirus and are likely to adopt ...

Safer and more broadly effective rotavirus vaccines could be achieved if initial investigations 1 into the boosting effect of plant-derived virus-like particles hold up in further trials.

"The risk of the original rotavirus vaccine was pretty small, and it was still taken off the market out of an abundance of caution once it was identified that there was a concern ...